ASHG: Australian Newborn WES Project Combines Hearing Loss Dx With Optional Secondary Results

Oct 19, 2018

|

SAN DIEGO (GenomeWeb) – Researchers in Australia have explored the clinical implementation of genomics by offering whole-exome sequencing as a diagnostic test to families with newborns affected by hearing loss while at the same time allowing parents to obtain secondary findings that could affect their child's health in the future.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

A Few, as Expected

The US Centers for Disease Control and Prevention has identified a small group of breakthrough COVID-19 cases, the Wall Street Journal reports.

For the Unknown Soldiers

The New York Times reports that the US Department of Defense is to use genetic genealogy approaches to identify the remains of unknown soldiers.

Prep for the Next One

Vox and Nature discuss the importance of preparing for the next pandemic.

Nature Papers Compare CtDNA Assays, Examine Lettuce Domestication, More

In Nature this week: comparison of five circulating tumor DNA assays, resequencing analysis of lettuce gives insight into its domestication, and more.

Featured White Papers

Congenica Enables Five Minute Diagnosis of Previously Unsolved Case

Congenica CNV Calling for Exomes Whitepaper

Congenica Splice Site Finder White Paper

Expediting an Accurate Diagnosis through Streamlined Clinical Workflows

Apr

16

Featured Webinar

The Post-Vaccine COVID Testing Landscape: A Virtual Roundtable Discussion

With COVID-19 vaccines rolling out, clinical labs and test developers are preparing for changes in both demand for testing and types of testing for SARS-CoV-2.

Apr

21

Featured Webinar

Single-cell Multiomics Analysis of Clonal Evolution in Myeloid Malignancies

This webinar, the first in a “Meet the Authors” series sponsored by Mission Bio, will discuss the application of single-cell analysis to decipher clonal evolution across several stages of disease development in myeloid malignancies.

Apr

22

Featured Webinar

Single-Cell Genomics Decodes the Developing Human Immune System

The human immune system is extremely complex, comprised of multiple cell types and states interacting in myriad ways to produce diverse cellular ecosystems.

Apr

29

Featured Webinar

A New Generation of PCR: At-home Testing and Preparing for Emerging Strains of COVID-19

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.

Menu

ASHG: Australian Newborn WES Project Combines Hearing Loss Dx With Optional Secondary Results

To read the full story....

Breaking News

Veracyte Preliminary Q1 Revenues Up 16 to 19 Percent, CFO to Retire

Wellcome Leap Launches $55M Program to Develop Disease-Specific Tissue Profiling Platforms

Cancer Dx Firm C2i Genomics Raises $100M in Financing

Tabula Rasa Healthcare, OneOme Form Precision Prescribing Alliance

Neanderthal Population Replacement Detected Using Spanish Cave Sediments

OncoDNA, Institut Curie Partner on Liquid Biopsy Research in Head and Neck Cancer

The Scan

A Few, as Expected

For the Unknown Soldiers

Prep for the Next One

Nature Papers Compare CtDNA Assays, Examine Lettuce Domestication, More

Featured White Papers

The Post-Vaccine COVID Testing Landscape: A Virtual Roundtable Discussion

Single-cell Multiomics Analysis of Clonal Evolution in Myeloid Malignancies

Single-Cell Genomics Decodes the Developing Human Immune System

A New Generation of PCR: At-home Testing and Preparing for Emerging Strains of COVID-19

What's Popular?

FDA-Led Group Evaluates Performance of RUO Liquid Biopsy Assays to Inform Practice Guidelines

With Luminex Acquisition, DiaSorin to Broaden MDx Portfolio, Expand US Presence

PerkinElmer Preliminary Q1 Revenues Grow 98 Percent; FDA Issues EUA for PCR COVID-19 Test

Arcedi Biotech Introduces NIPT Analyzing DNA From Rare Fetal Cells in Maternal Blood

Labs Craft SARS-CoV-2 Variant Genotyping Assays for Screening, Surveillance

Sponsorships